3 completed, 1 terminated. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 1 | Terminated 1 |
Follow Speedel Pharma Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase IIa Study to Investigate the Efficacy and Safety of SPP635 in Diabetic and Hypertensive Patients With Albuminuria SPP635 - Hypertension, Type II Diabetes Mellitus | Phase 2 | Completed | Speedel Pharma Ltd. | 50 | 2007-11-01 | 2008-11-21 |
| Phase IIa Safety and Efficacy Study of SPP635 in Mild to Moderate Hypertension SPP635 (drug) - Hypertension | Phase 2 | Completed | Speedel Pharma Ltd. | 35 | 2006-10-01 | 2007-10-30 |
| To Determine the Effects of Avosentan on Doubling of Serum Creatinine, End Stage Renal Disease and Death in Diabetic Nephropathy SPP301 - Diabetic Nephropathy | Phase 3 | Terminated | Speedel Pharma Ltd. | 2364 | 2005-07-01 | 2007-10-05 |
| A Clinical Study to Assess the Safety of PEG-Hirudin (SPP200) Compared to Heparin in Patients Who Are on Haemodialysis PEG-hirudin - Chronic Kidney Failure, Vascular Graft Occlusion | Phase 2 | Completed | Speedel Pharma Ltd. | 260 | 2003-11-01 | 2007-10-05 |
Hypertension (2) · Kidney Failure, Chronic (2) · Diabetes Mellitus, Type 2 (1) · Diabetic Nephropathies (1) · Graft Occlusion, Vascular (1)
Avosentan (1) · Pharmaceutical Preparations (1) · polyethyleneglycol-hirudin (1)
United States (2) · Germany (1) · Ireland (1)
Jessica M Mann, MD, PhD (1) · Jessica Mann, MD, PhD (1) · Maria Nicolaides, Dr. (1) · Sybille Baumann-Noss, MD (1)
2005 (1)